Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02886286 · ClinicalTrials.gov registry record · Phase 4
Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
A Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT02886286 is a Phase 4 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT02886286, a Phase 4 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the local anesthetic bupivacaine delivered intrathecally in small doses via PTM self-administered boluses significantly improves the breakthrough pain and functional status of patients with chronic intractable pain who are managed with an intrathecal drug delivery system.
Interventions
- DRUG Bupivacaine
- DRUG Opioid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02886286
The ClinicalTrials.gov registry entry for NCT02886286 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT02886286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02886286 about?
NCT02886286 is a clinical study titled "Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain". The purpose of this study is to determine whether the local anesthetic bupivacaine delivered intrathecally in small doses via PTM self-administered boluses significantly improves the breakthrough pain and functional status of patients with chronic intractable pain who are managed with an intrathecal...
What is the current status of trial NCT02886286?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2016-05. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02886286?
The interventions under investigation include: Bupivacaine (DRUG), Opioid (DRUG).
Who is sponsoring clinical trial NCT02886286?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.